Close Menu
My Blog

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Nautilus debuts Voyager platform in push toward next-gen proteomics

    March 1, 2026

    First-in-Human Success for Prenatal Stem Cell Therapy in Spina Bifida

    February 28, 2026

    Pressure-Driven Pathway Links Liver Congestion to Fibrosis and Cancer

    February 28, 2026
    Facebook X (Twitter) Instagram
    X (Twitter) YouTube
    My BlogMy Blog
    Sunday, March 1
    • Home
    • About Us
    • Healthy Living
    • DNA & Genetics
    • Podcast
    • Shop
    My Blog
    Home»DNA & Genetics»How Fat Type Shapes Hypertension Risk
    DNA & Genetics

    How Fat Type Shapes Hypertension Risk

    adminBy adminJanuary 15, 2026No Comments4 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
    The Scientist Logo
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Scientists revealed how beige fat restrains an enzyme that promotes blood vessel constriction.

    Image credit:Weslie R. and William H. Janeway, Laboratory of Molecular Metabolism at The Rockefeller University

    Despite the message many fitness influencers keep trying to push, fats are essential for the body to function properly. Too little and issues with hormone production, vitamin absorption, and nerve function might crop up. But too much fat isn’t good either. Decades of patient data unequivocally show that obesity increases the risk of hypertension, which subsequently raises the likelihood of developing cardiovascular diseases and strokes.1

    But not all fat is the same. It’s the relative amounts of different types that’s key to blood pressure regulation, rather than the total fat level. Excess white fat, which the body uses to store calories, is associated with hypertension. Contrastingly, brown fat, which the body burns up to generate energy and heat, is linked to lower risk of high blood pressure.

    “A couple of years ago, we conducted a large clinical study where we found that individuals that have brown fat had lower odds of having different cardiometabolic diseases, including type 2 diabetes and hypertension,” said Mascha Koenen, a molecular biologist at Rockefeller University, in a statement. “We had no mechanistic understanding why that would be the case.”

    Paul Cohen and Mascha Koenen are molecular biologists at Rockefeller University who investigate the molecular origins of metabolic disease related to obesity.

    Lori Chertoff for The Rockefeller University

    To gain a deeper understanding of this relationship, Koenen and her colleagues studied beige fat—the rodent equivalent of human brown fat—and its effect on vascular architecture and blood pressure in mice. Their findings, published in Science, showed that beige fat suppresses an enzyme that promotes stiffening of blood vessels and hypertension.2 These findings highlight brown fat as a new therapeutic target for high blood pressure and cardiovascular diseases.

    “We started with a surprising and unexplained association and demonstrated a causal relationship and a biological mechanism,” said Paul Cohen, a physician and molecular biologist at Rockefeller University and coauthor of the study.

    Human and rodent bodies have multiple heat-producing fat stores, some of which surround blood vessels to form the perivascular adipose tissue (PVAT). Cells in the PVAT secrete molecules that can cross the wall of the blood vessels and alter the architecture of the tissue within. Depending on the relative amounts of fat cell types in the PVAT, the molecules released can cause inflammation and constriction of the vessel walls. This made for an ideal model to study the relationship between beige fat and vascular health.

    Next, the team created mutant mice that lacked beige fat production. These animals had higher levels of white fat markers in their PVAT, increased blood pressure, and stiff and fibrous tissue around their blood vessels as compared to their beige-fat-producing counterparts. When the researchers treated healthy vascular tissue with molecules secreted by fat cells lacking beige fat, they observed similar structural changes. Using single cell RNA-sequencing, Koenen and her colleagues identified quiescin sulfhydryl oxidase 1 (QSOX1) as the mediator of these changes, a tissue remodeling enzyme released by PVAT. In the absence of beige fat, levels of QSOX1 shot up, causing blood vessels to stiffen and constrict, which in turn caused the heart to work harder to pump blood. Mice lacking the Qsox1 gene did not have vascular dysfunction, even in the absence of beige fat.

    “We’ve now confirmed that it’s not just fat, per se, that contributes to hypertension, but the type of fat,” Cohen said.

    Koenen and Cohen want to now move beyond mice and look for genetic determinants of brown fat function in humans. “The more we know about these molecular links, the more we can move towards conceiving of a world where we can recommend targeted therapies based on an individual’s medical and molecular characteristics,” Cohen said.

    Fat Hypertension Risk Shapes Type
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Previous ArticleFour Markers Capture Triple-Negative Breast Cancer Cells in Blood Samples
    Next Article Agenus Closes Strategic Immunotherapeutic Collaboration with Zydus Lifesciences
    admin
    • Website

    Related Posts

    A Video Report from AGBT

    February 27, 2026

    Novo Nordisk, Vivtex Ink Up to $2.1B Deal to Develop Oral Biologics for Metabolic Conditions

    February 27, 2026

    Increasing Rice Yields with Gene-Informed Selective Breeding

    February 27, 2026

    Mutant p53 Selective Reactivation Demonstrated in Advanced Solid Tumors

    February 27, 2026
    Leave A Reply Cancel Reply

    Our Picks

    9 Time-Saving Kitchen Gadgets for Fall at Amazon

    September 5, 2025

    Why Exercise Is So Important For Heart Health, From An MD

    September 5, 2025

    An Engineered Protein Helps Phagocytes Gobble Up Diseased Cells

    September 5, 2025

    How To Get Rid Of Hangnails + Causes From Experts

    September 5, 2025
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Don't Miss
    Longevity

    Nautilus debuts Voyager platform in push toward next-gen proteomics

    By adminMarch 1, 20260

    Company’s new benchtop system promises a clearer view of proteins following validation at a leading…

    First-in-Human Success for Prenatal Stem Cell Therapy in Spina Bifida

    February 28, 2026

    Pressure-Driven Pathway Links Liver Congestion to Fibrosis and Cancer

    February 28, 2026

    A cellular atlas of aging comes into focus

    February 28, 2026

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    About Us

    At FineGut, our mission is simple: to enhance your self-awareness when it comes to your gut health. We believe that a healthy gut is the foundation of overall well-being, and understanding the brain–gut connection can truly transform the way you live.

    Our Picks

    9 Time-Saving Kitchen Gadgets for Fall at Amazon

    September 5, 2025

    Why Exercise Is So Important For Heart Health, From An MD

    September 5, 2025

    An Engineered Protein Helps Phagocytes Gobble Up Diseased Cells

    September 5, 2025
    Gut Health

    Nautilus debuts Voyager platform in push toward next-gen proteomics

    March 1, 2026

    First-in-Human Success for Prenatal Stem Cell Therapy in Spina Bifida

    February 28, 2026

    Pressure-Driven Pathway Links Liver Congestion to Fibrosis and Cancer

    February 28, 2026
    X (Twitter) YouTube
    • Contact us
    • Privacy Policy
    • Disclaimer
    • Terms and Conditions
    © 2026 finegut.com. Designed by Pro.

    Type above and press Enter to search. Press Esc to cancel.